Market Tracker

08/27 2:56pm ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

18.07
Real-Time Quote
 +0.18 / +1.01%
Today’s Change
8.48
Today|||52-Week Range
18.20
+39.54%
Year-to-Date

Today’s Trading

Previous close17.89
Today’s open18.15
Day’s range17.73 - 18.20
Volume1,284,074
Average volume (3 months)1,509,294
Market cap$1.6B
Dividend yield--
Data as of 2:41pm ET, 08/27/2014

Growth & Valuation

Earnings growth (last year)-63.84%
Earnings growth (this year)-40.52%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales149.87
Price/Book32.57

Competitors

 Today’s
change
Today’s
% change
ABCOAdvisory Board Co-0.02-0.04%
NKTRNektar Therapeutics-0.03-0.17%
DYAXDyax Corp+0.09+0.89%
ARIAARIAD Pharmaceutical...-0.14-2.15%
Data as of 2:56pm ET, 08/27/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$7.0M
Annual profit (last year)-$46.7M
Net profit margin-667.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ronald Bentsur
Chief Operating Officer &
Executive Vice President
Gregory P. Madison
Corporate headquarters
New York, New York

Forecasts